NON SMALL CELL LUNG CANCER METASTATIC
Clinical trials for NON SMALL CELL LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise for tough lung cancer
Disease control CompletedThis study tested whether adding bevacizumab to osimertinib helps people with advanced lung cancer that has a specific genetic change (EGFR and T790M mutations). 155 adults who had already tried other treatments took part. The main goal was to see if the combination slowed cancer…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 17, 2026 05:49 UTC
-
New strategy zaps lung cancer spots before they grow
Disease control CompletedThis study tested whether giving focused treatments (like heat or freezing) to cancer spots in the body can help control advanced lung cancer that has spread. The approach uses a blood test to find tiny bits of cancer DNA (minimal residual disease) and treats when levels rise. 37…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
New cocktail of cancer drugs tested for safety in advanced tumors
Disease control CompletedThis early-phase study tested the safety of combining several cancer drugs (niraparib, TSR-022, bevacizumab, chemotherapy, and TSR-042) in 60 people with advanced or metastatic solid tumors. The goal was to find safe doses for each combination to use in later studies. Participant…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Tesaro, Inc. • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Radiation boost slows spread of advanced lung cancer in small trial
Disease control CompletedThis study tested whether adding a precise type of radiation (SBRT) to standard targeted drug therapy could help control advanced lung cancer that has spread. It included 27 people with stage IV non-small cell lung cancer that had specific gene changes (EGFR, ALK, or ROS1) and wa…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for Hard-to-Treat lung cancer brain metastases
Disease control CompletedThis study tested a combination of three drugs—high-dose furmonertinib, bevacizumab, and pemetrexed given into the spinal fluid—in 46 people with a specific type of lung cancer (EGFR-mutated) that had spread to the lining of the brain (meningeal metastasis). The goal was to see i…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Can lung cancer patients safely stop immunotherapy early? new trial investigates.
Disease control CompletedThis study looked at 265 people with advanced non-small cell lung cancer whose tumors have a protein called PD-L1. All patients received a combination of two immunotherapy drugs (nivolumab and ipilimumab) for 6 months. Then, half stopped treatment and were watched closely, while …
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Experimental combo shows promise in tough lung cancer
Disease control CompletedThis early-phase study tested whether adding an experimental drug called plinabulin to the standard immunotherapy nivolumab is safe and effective for people with advanced non-small cell lung cancer that has spread. The study enrolled 18 adults whose cancer had worsened after prio…
Matched conditions: NON SMALL CELL LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated May 04, 2026 16:30 UTC